Format

Send to

Choose Destination
Am J Clin Nutr. 2014 Dec;100(6):1422-36. doi: 10.3945/ajcn.114.095315. Epub 2014 Oct 15.

Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials.

Author information

1
From the Chronic Disease Research Institute, Department of Nutrition, School of Public Health, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Abstract

BACKGROUND:

n-3 PUFAs play an important role in cognitive function.

OBJECTIVE:

The objective was to investigate the effect of n-3 PUFA supplements on cognitive development, function, and decline throughout the life span.

DESIGN:

The study included randomized controlled trials and provided ≥3 mo of treatment. Potential studies were independently screened in duplicate, and study characteristics and outcomes were extracted. A meta-analysis was performed by using fixed- or random-effects models. The results are presented as standardized mean differences (SMDs) with 95% CIs.

RESULTS:

Of the 3692 citations retrieved, 34 studies of a total of 12,999 participants (1031 infants, 1517 children, 3657 adults, and 6794 elderly individuals) were included. Compared with placebo, n-3 PUFA supplements significantly improved cognitive development in infants, including the Mental Development Index (SMD: 0.33; 95% CI: 0.15, 0.52), the Psychomotor Development Index (0.27; 95% CI: 0.09, 0.45), and language (0.27; 95% CI: 0.13, 0.42), motor (0.29; 95% CI: 0.14, 0.43), and cognitive (0.31; 95% CI: 0.16, 0.45) abilities. However, n-3 PUFAs did not promote cognitive function in terms of composite memory, executive function, and processing speed domains in children, adults, or the elderly, except for the attention domain. No association was found between n-3 PUFA intake and improvements in cognitive performance in terms of recognition, immediate and delayed word recall, digit span backward and forward tests, rapid visual information processing, verbal fluency, and simple and choice reaction times. In addition, n-3 PUFA supplements were not associated with improvements in cognitive decline or with any effects on Alzheimer disease in elderly people.

CONCLUSIONS:

n-3 PUFA supplements may significantly improve cognitive development in infants but do not improve cognitive performance in children, adults, or the elderly. n-3 PUFA intake, especially that of DHA supplements, may benefit cognitive development during infancy.

KEYWORDS:

cognitive function; infancy; life span; meta-analysis; n–3 polyunsaturated fatty acid

PMID:
25411277
DOI:
10.3945/ajcn.114.095315
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center